Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Daniel Fernandez
    Member
    • Nov 2011
    • 31

    #1

    Exonerate GFF in Artemis

    Hi,

    May be this is very simple question, I'm beginner in bioinformatics.

    I'm trying to run exonerate, I tested with a partial chr1 of A. thaliana, and extract its mRNA, only for test. I generate its GFF of the query, the partial chr1, and the GFF of its genes, but when I tried to load in artemis, it doesn't work, when I load the GFF, query or target, only show the partial chr1 fasta.

    It is not a problem with artemis, because I load the augustus ab-inito.GFF and work.

    These are my commands:

    Code:
    exonerate -q At.chr1.fa -Q dna -t At.genes.fa -T dna -m e2g --refine region --showalignment no --showvulgar no --showquerygff yes > At.chr1.gff
    exonerate -q At.chr1.fa -Q dna -t At.genes.fa -T dna -m e2g --refine region --showalignment no --showvulgar no --showtargetgff yes > At.genes.gff
    
    artemis At.chr1.fa + At.chr1.gff		# only show At.chr1.fa
    artemis At.chr1.fa + At.genes.gff		# only show At.chr1.fa
    artemis At.chr1.fa + At.chr1.gff + At.genes.gff	# only show At.chr1.fa
    Last edited by Daniel Fernandez; 06-06-2012, 10:00 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
40 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...